Stories & News
Resources
Stay Informed
Stay Informed
May 7, 2025
Here’s What Analysts Asked About Pfizer’s Strategy & Priorities on its Q1 2025 Earnings Call
Stories
April 29, 2025
Pfizer Reports Solid First-Quarter 2025 Financial Results and Reaffirms Full-Year Guidance
Stories
April 3, 2025
Quiz: Did You Listen to Season 4 of Pfizer’s ‘Science Will Win’ Podcast?
Stories
March 12, 2025
Inflammation and Immunology Discovery: A Day in the Life of Pfizer Scientist Dr. Thomas Wynn
Stories
March 7, 2025
Pfizer Marks 16 Years of Annual Dividend Increases with 345th Consecutive Quarterly Dividend Payments
Stories
February 12, 2025
Here’s What Analysts Asked About Pfizer’s Research and Development Strategy as Part of its Q4-FY 2024 Earnings Call
Stories
February 6, 2025
2024 Key Milestones
Stories
February 4, 2025
Pfizer Reports Strong Q4 and Full-Year 2024 Results; Strengthens Company for the Future
Stories
January 22, 2025
Pfizer’s 2025 Priorities: A Roadmap to Innovation and Excellence
Stories
December 20, 2024
Advancing Oncology Innovation: Celebrating One Year of Pfizer + Seagen
Stories
December 19, 2024
Communicating Pfizer’s Value: A Conversation with Francesca DeMartino
Stories
October 29, 2024
Pfizer Delivers Strong Third-Quarter 2024 Financial Results and Raises 2024 Guidance
Stories
October 15, 2024
Expanding Our Governance: Meet the Newest Members of Pfizer’s Board of Directors
Stories
July 30, 2024
Pfizer Delivers Strong Second-Quarter 2024 Financial Results and Raises 2024 Guidance
Stories
June 28, 2024
Celebrate Our 175th Anniversary by Testing Your Pfizer-Knowledge!
Stories
June 24, 2024
Celebrating 175 Years of Changing Lives at Pfizer
Stories
May 29, 2024
A Conversation with Chris Boshoff: Leading Pfizer’s Oncology Organization
Stories
May 20, 2024
World Clinical Trials Day 2024: Pfizer’s Commitment to Improving the Clinical Trial Experience
Stories
May 1, 2024
Pfizer Reports Solid First-Quarter 2024 Financial Results
Stories
April 8, 2024
Quiz: Did You Review Pfizer’s 2023 Impact Report?
Stories
March 14, 2024
Pfizer’s Journey Towards a Better Tomorrow: 2023 Impact Report
Stories
March 7, 2024
Pfizer’s Oncology Innovation Day: Company Launches Strategy to Deliver Next Era of Meaningful Treatments for Cancer Patients
Stories
February 9, 2024
Pfizer’s Albert Bourla Talks Seagen Acquisition on CNBC’s Mad Money with Jim Cramer
Stories
February 5, 2024
A Year in Review
Stories
January 30, 2024
Pfizer Reports Fourth Quarter and Full-Year 2023 Results; Enters 2024 With a Solid Foundation
Stories
November 14, 2023
How much do you know about Pfizer?
Stories
October 31, 2023
Pfizer Reports Third Quarter Results
Stories
October 12, 2023
How Pfizer’s Women Leaders Are Breaking Barriers in Vaccine Science
Stories
October 2, 2023
Pfizer’s Rocky Mount Facility Restarts Production: First Step Towards Full Recovery After Tornado
Stories
September 27, 2023
Engaging Our Shareholders: Pfizer Announces New Chief Investor Relations Officer
Stories
September 5, 2023
Pfizer’s Approach to Incorporating Sustainability in the Development of Medicines
Stories
August 1, 2023
Pfizer’s Second Quarter: Solid Financial Performance and Several Pipeline Advances
Stories
July 14, 2023
Pfizer’s Long Streak of Returning Capital to Investors
Stories
June 6, 2023
Pfizer’s Commitment to Improving Diversity in Clinical Trials: A Quiz
Stories
May 2, 2023
Pfizer’s First-Quarter Results: A Solid Start to the Year
Stories
April 12, 2023
A New Era of Innovations in Oncology
Stories
March 31, 2023
Investing Capital in the Next Generation of Potential Breakthroughs: A Conversation with Pfizer’s Chief Business Innovation Officer
Stories
March 16, 2023
Pfizer is Making Continued Progress on its ESG Strategy: 2022 ESG Report
Stories
March 13, 2023
Enhancing Pfizer’s Position in Oncology
Stories
February 3, 2023
Marking A Year’s Milestones
Stories
January 31, 2023
A Record-Breaking Year and Strong Fourth Quarter for Pfizer
Stories
January 20, 2023
Pfizer Expands Commitment to Creating a “Healthier World”
Stories
January 3, 2023
Potential for Future Growth Through Internal Innovation
Stories
December 19, 2022
A 60-Year Quest for An RSV Vaccine: A Conversation with Dr. William Gruber
Stories
November 18, 2022
Pfizer Supports Florida Residents with Hurricane Ian Relief Efforts
Stories
November 1, 2022
Pfizer Third Quarter Sees Multiple Pipeline Advances
Stories
October 20, 2022
Confronting the Challenge of Climate Change: Pfizer’s Sustainability Efforts
Stories
September 23, 2022
Developing a Potential mRNA Influenza Vaccine
Stories
September 9, 2022
One Step Closer in the Global Fight Against Respiratory Syncytial Virus (RSV)
Stories
September 8, 2022
Putting Capital to Work
Stories
August 15, 2022
Lyme Disease Vaccine Candidate Phase 3 Trial to Begin
Stories
July 28, 2022
Pfizer’s Second Quarter Sees Historic Sales and Bold Goals
Stories
July 12, 2022
“Investments to Improve the Lives of Patients”: A Conversation with Pfizer’s New CFO
Stories
June 14, 2022
Access and Affordability: How Pfizer Is Impacting People with Breakthrough Medicines and Vaccines
Stories
June 2, 2022
Seeking Breakthrough Therapies for Immuno-Inflammatory Diseases
Stories
May 24, 2022
Better Medicines through Health Equity: Talking to Chief Medical Officer Dr. Aida Habtezion
Stories
May 3, 2022
Pfizer Results: Strong Performance and A Commitment to Be A Force for Good
Stories
April 25, 2022
Pfizer Is Using AI to Discover Breakthrough Medicines
Stories
March 17, 2022
The Confidence to Rise to Any Challenge: Pfizer’s 2021 ESG Report
Stories
March 14, 2022
Pfizer’s Twelve Years of Dividend Increases
Stories
March 3, 2022
On Rare Diseases Day, New Partnerships and Investments Could Deliver Potential Breakthroughs
Stories
March 1, 2022
Using Viruses to Fight Cancer: A New Approach to Treating Solid Tumors
Stories
February 21, 2022
A “Fundamentally Changed” Company: Pfizer Reports Strong 2021 Earnings
Stories
February 18, 2022
Variant-Based Vaccine Trial Key to Virus Vigilance
Stories
January 27, 2022
Pfizer’s Roadmap for mRNA, A “Game-Changer Technology”
Stories
January 24, 2022
Pfizer Makes Progress on Multiple Fronts with COVID-19 Treatment Candidate
Stories
December 10, 2021
Two Billion Doses by the End of 2022: Pfizer’s Commitment to Equitable Access
Stories
November 10, 2021
A Pill That Could Potentially Save Lives: Pfizer Treatment Reduced Risk of Hospitalization or Death from COVID-19 in Interim Analysis
Stories
November 9, 2021
CEO Albert Bourla on Transforming Pfizer
Stories
November 2, 2021
Pfizer Inc. Third Quarter 2021 Financial Results
Stories
October 28, 2021
A Potential Breakthrough in the Fight Against RSV? Pfizer’s Vaccine Candidate Enters Phase 3 Trials
Stories
October 20, 2021
What Can You Tell Me About Potential COVID-19 Vaccines in Children? Hear About Some of Pfizer’s Research
Stories
October 15, 2021
Shot of a Lifetime: How Pfizer and BioNTech Developed and Manufactured a COVID-19 Vaccine in Record Time
Stories
October 5, 2021
The Company You Keep: Pfizer Partners for Success
Stories
September 28, 2021
Pfizer: Improving the Pace of Innovation
Stories
September 20, 2021
Pfizer Supports Affordable Access Through Biosimilars
Stories
September 15, 2021
Pfizer’s Streak of Returning Cash to Shareholders
Stories
September 7, 2021
Pfizer’s Next Potential Breakthrough Vaccine Could Target The Flu
Stories
Back
Loading
Page 1 of 42
Next
Loading